- Home
- GRABW vs SCLXW Comparison
GRABW vs SCLXW Comparison
Compare GRABW & SCLXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRABW
- SCLXW
- Stock Information
- Founded
- GRABW N/A
- SCLXW N/A
- Country
- GRABW Singapore
- SCLXW United States
- Employees
- GRABW 10604
- SCLXW 113
- Industry
- GRABW Business Services
- SCLXW Biotechnology: Pharmaceutical Preparations
- Sector
- GRABW Consumer Discretionary
- SCLXW Health Care
- Exchange
- GRABW Nasdaq
- SCLXW Nasdaq
- Market Cap
- GRABW N/A
- SCLXW N/A
- IPO Year
- GRABW N/A
- SCLXW 2021
- Fundamental
- Price
- GRABW $0.44
- SCLXW $0.24
- Analyst Decision
- GRABW
- SCLXW
- Analyst Count
- GRABW 0
- SCLXW 0
- Target Price
- GRABW N/A
- SCLXW N/A
- AVG Volume (30 Days)
- GRABW N/A
- SCLXW N/A
- Earning Date
- GRABW N/A
- SCLXW N/A
- Dividend Yield
- GRABW N/A
- SCLXW N/A
- EPS Growth
- GRABW N/A
- SCLXW N/A
- EPS
- GRABW N/A
- SCLXW N/A
- Revenue
- GRABW N/A
- SCLXW N/A
- Revenue This Year
- GRABW N/A
- SCLXW N/A
- Revenue Next Year
- GRABW N/A
- SCLXW N/A
- P/E Ratio
- GRABW N/A
- SCLXW N/A
- Revenue Growth
- GRABW N/A
- SCLXW N/A
- 52 Week Low
- GRABW N/A
- SCLXW N/A
- 52 Week High
- GRABW N/A
- SCLXW N/A
- Technical
- Relative Strength Index (RSI)
- GRABW 50.15
- SCLXW N/A
- Support Level
- GRABW $0.34
- SCLXW N/A
- Resistance Level
- GRABW $0.45
- SCLXW N/A
- Average True Range (ATR)
- GRABW 0.04
- SCLXW 0.00
- MACD
- GRABW -0.00
- SCLXW 0.00
- Stochastic Oscillator
- GRABW 63.64
- SCLXW 0.00
About GRABW Grab Holdings Limited Warrant
Founded in 2012, Grab provides ride-sharing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast-Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging commission to both sides. Grab has a leading market share in and derives 89% of its revenue from its core businesses, ride-sharing and food delivery. Singapore and Malaysia contributed 58% of revenue as of end-2021. Grab's main competitors in Southeast Asia are Foodpanda and Gojek, the ride-sharing arm of GoTo. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.
About SCLXW Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.